Mengjie Ding

No. 1 Jianshe East Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis.

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis.

Journal: Therapeutic advances in medical oncology

Published: September 04, 2025

Retraction Note: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.

Retraction Note: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.

Journal: Journal of translational medicine

Published: October 29, 2024

Minimal residual disease detection in lymphoma: methods, procedures and clinical significance.

Minimal residual disease detection in lymphoma: methods, procedures and clinical significance.

Journal: Frontiers in immunology

Published: May 09, 2024

Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.

Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.

Journal: Aging

Published: August 01, 2023

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.

Journal: Cancer medicine

Published: September 09, 2022

Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.

Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.

Journal: Journal of cancer research and clinical oncology

Published: July 21, 2022

The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China.

The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China.

Journal: Frontiers in nutrition

Published: June 29, 2022

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: June 16, 2022

Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman Disease.

Clinical and Molecular Characteristics of 60 Patients With Human Immunodeficiency Virus-Negative Castleman Disease.

Journal: Frontiers in immunology

Published: March 18, 2022

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

Journal: Cancer biology & medicine

Published: October 11, 2021

Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.

Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.

Journal: Frontiers in oncology

Published: March 29, 2021

GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.

GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.

Journal: Archives of biochemistry and biophysics

Published: March 07, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026